Douglass Winthrop Advisors, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Douglass Winthrop Advisors, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2014$418,000
+21.5%
27,000
-5.3%
0.04%
+15.6%
Q3 2014$344,000
-7.5%
28,500
-1.7%
0.03%
-5.9%
Q2 2014$372,000
+6.0%
29,0000.0%0.03%
-2.9%
Q1 2014$351,000
+3.2%
29,000
-3.3%
0.04%0.0%
Q4 2013$340,000
+8.6%
30,0000.0%0.04%
-2.8%
Q3 2013$313,000
-6.6%
30,000
+3.4%
0.04%
-12.2%
Q2 2013$335,00029,0000.04%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2014
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders